Increased urinary N-telopeptide cross-linked type 1 collagen predicts bone loss in patients with inflammatory bowel disease

American Journal of Gastroenterology

Volumn 95, Issue 3, 2000, Pages 699-704

  Dresner Pollak, Rivka ^c   Karmeli, Fanny ^b   Eliakim, Rami ^a   Ackerman, Zvi ^a   Rachmilewitz, Daniel ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ALKALINE PHOSPHATASE BONE ISOENZYME; COLLAGEN TYPE 1; PARATHYROID HORMONE;

ADULT; ARTICLE; BONE DENSITY; BONE TURNOVER; CLINICAL ARTICLE; CROHN DISEASE; DISEASE DURATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; FEMALE; FEMUR NECK; HUMAN; ILEUM RESECTION; LUMBAR SPINE; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; ULCERATIVE COLITIS; URINARY EXCRETION;

ADULT; BONE DENSITY; BONE RESORPTION; COLITIS, ULCERATIVE; COLLAGEN; COLLAGEN TYPE I; CROHN DISEASE; DENSITOMETRY, X-RAY; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PEPTIDES;

EID: 0033994691     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9270(99)00909-0     Document Type: Article

References (36)

1. Pigot F., Roux C., Chaussade S., et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci. 37:1992;1396-1403.
2. Abitol V., Roux C., Chaussade S., et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology. 108:1995;417-422.
3. Bernstein C.N., Seeger L.L., Sayre J.W., et al. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res. 10:1995;250-256.
4. Bjarnson I., Macpherson A., Mackintosh C., et al. Reduced bone density in patients with inflammatory bowel disease. Gut. 40:1997;228-233.
5. Dresner-Pollak R., Karmeli F., Eliakim R., et al. Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol. 93:1998;1483-1490.
6. Roux C., Abitol V., Chaussade S., et al. Bone loss in patients with inflammatory bowel disease A prospective study . Osteoporosis Int. 5:1995;156-160.
7. Motley R.J., Crawley E.O., Evans C., et al. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut. 29:1988;1332-1336.
8. Clements D., Motley R.J., Evans W.D., et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scan J Gastroenterol. 27:1992;1055-1060.
9. Motley R.J., Clements D., Evans W.D., et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner. 23:1993;95-104.
10. Staun M., Tjellesen L., Thale M., et al. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol. 32:1997;226-232.
11. Seibel M.J., Pols H.A.P. Clinical application of biochemical markers of bone metabolism. Bilezikian J.P., Raisz L.G., Rodan G. Principles of bone biology. 1996;1293-1312 Academic Press, San Diego.
12. Silvennoinen J., Risteli L., Karttunen T., et al. Increased degradation of type 1 collagen in patients with inflammatory bowel disease. Gut. 38:1996;223-228.
13. Robinson R.J., Iqbal S.J., Abrams K., et al. Increased bone resorption in patients with Crohn's disease. Aliment Pharmacol Ther. 12:1998;699-705.
14. Bjarnason I., Macpherson C., Buxton-Thomas M., et al. Reduced bone mineral density in patients with inflammatory bowel disease. Gut. 40:1997;228-233.
15. Bischoff S.C., Herrmann A., Goke M., et al. Altered bone metabolism in inflammatory bowel disease. Am J Gastroenterol. 92:1997;1157-1163.
16. Kanis J.A., Melton L.J. III, Christiansen C., et al. The diagnosis of osteoporosis. J Bone Miner Res. 9:1994;1137-1141.
17. Garnero P., Grimaux M., Demiaux B., et al. Measurement of serum osteocalcin with a human specific two site radioimmunoassay. J Bone Miner Res. 7:1992;1389-1397.
18. Garnero P., Delmas P.D. Assessment of the serum levels of bone alkaline phosphatase with a new radiometric assay in patients with metabolic bone disease. J Clin Endocrinol Metab. 77:1993;1046-1053.
19. Hanson D.A., Weis M.A.E., Bollen A.-M., et al. A specific immunoassay for monitoring human bone resorption Quantitation of type 1 collagen cross-linked N-telopeptides in urine . J Bone Miner Res. 7:1992;1251-1258.
20. Christiansen C., Riis B.J., Rodboro P. Prediction of rapid bone loss in postmenopausal women. Lancet. 1:1987;1105-1108.
21. Garnero P., Hausherr E., Chapuy M.-C., et al. Markers of bone resorption predict hip fracture in elderly women The EPIDOS prospective study . J Bone Miner Res. 11:1996;1531-1538.
22. Einhorn T.A. Bone strength The bottom line . Calcif Tissue Int. 51:1992;333-339.
23. Rosen H.N., Dresner-Pollak R., Moses A.C., et al. Specificity of urinary excretion of cross-linked N-telopeptides of type 1 collagen as a marker of bone turnover. Calcif Tissue Int. 54:1994;26-29.
24. Schneider D.L., Barrett-Conors E.L. Urinary N-telopeptide levels discriminate normal, osteopenic, and osteoporotic bone mineral density. Arch Intern Med. 157:1997;1241-1245.
25. Chestnutt C.H. III, Bell N.H., Clark G.S., et al. Hormone replacement therapy in postmenopausal women Urinary N-telopeptide of type 1 collagen monitors therapeutic effect and predicts response of bone mineral density . Am J Med. 102:1997;29-37.
26. Greenspan S.L., Parker R.A., Ferguson L., et al. Early changes in biochemical markers of bone turnover predict the long-term response to alendronate therapy in representative elderly women A randomized clinical trial . J Bone Miner Res. 13:1998;1431-1439.
27. Greenspan S.L., Dresner Pollak R., Parker R.A., et al. Diurnal variation of bone mineral turnover in elderly men and women. Calcif Tissue Int. 60:1997;419-423.
28. Dresner Pollak R., Rosen H.N., Clemens J.D., et al. Reliability of spot urine collection for measurement of bone resorption by cross-linked N-telopeptide assay in the elderly. J Bone Miner Res. 8:(suppl):1993;S809.
29. Vogelsang H., Ferenci P., Woloszczuk W., et al. Bone disease in vitamin D deficient patients with Crohn's disease. Dig Dis Sci. 34:1989;1094-1099.
30. Compston J.E., Judd D., Crawley E.O., et al. Osteoporosis in patients with inflammatory bowel disease. Gut. 28:1987;410-415.
31. Silvennoinen J.A., Karttunen T.J., Niemela S.E., et al. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 37:1995;71-76.
32. Jahnsen J., Falch J.A., Aadland E., et al. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis A population based study . Gut. 40:1997;313-319.
33. Clements D., Compston J.E., Evans W.D., et al. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut. 34:1993;1543-1546.
34. Bernstein C.N., Seeger L.L., Anton P.A., et al. A randomized, placebo controlled trial of calcium supplementation for decreased bone density in corticosteroid-using patients with inflammatory bowel disease A pilot study . Aliment Pharmacol Ther. 10:1996;777-786.
35. Vogelsang H. Prevention of bone mineral loss in patients with Crohn's disease by long-term oral vitamin D supplementation. Eur J Gastroenterol Hepatol. 7:1995;609-614.
36. Robinson R.J., Krzywicki T., Almond L., et al. Effect of a low-impact exercise program on bone mineral density in Crohn's disease A randomized controlled trial . Gastroenterology. 115:1998;36-41.